Stock & Company Details
Capricor Therapeutics Inc $CAPR
Price:
N/A
N/A
58M
$466M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CAPR technical indicators
Latest Capricor Therapeutics Inc (CAPR) indicator readings as of 2026-10-09.
CAPR's 14-day RSI is 42.0, in neutral territory. At $7.83 it is trading 64.9% below its 200-day moving average of $22.33, and above its 50-day average of $7.64. Price sits near the lower Bollinger Band ($7.60 to $9.64). ADX reads 9.9, indicating a range-bound market rather than a trend.
Overview
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Finance Bot
Ask your questions
Start by typing a question below.
